Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits
- PMID: 7112507
- DOI: 10.1016/0049-3848(82)90089-5
Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits
Abstract
Heparin and heparin fragments of different molecular weight and with different anti-factor Xa/APTT activity ratios were studied with respect to their ability to inhibit thrombus formation in an animal model. It is concluded that: a) Neither anti-factor Xa nor the APTT activity alone is a good reflector of the antithrombotic activity. b) Anti-factor Xa active fragments must have a minimum molecular weight in order to elicit good antithrombotic activity. c) High affinity for antithrombin III is important for good antithrombotic activity. d) A heparin fragment of molecular weight 4 000 has the same antithrombotic activity as heparin but less effect on the clotting time.
Similar articles
-
In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.Haemostasis. 1986;16(2):82-6. doi: 10.1159/000215277. Haemostasis. 1986. PMID: 3710297
-
Antithrombotic and bleeding effects of a low molecular weight heparin fraction.Biochem Pharmacol. 1985 Sep 15;34(18):3305-8. doi: 10.1016/0006-2952(85)90350-8. Biochem Pharmacol. 1985. PMID: 4038339
-
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.Thromb Haemost. 1994 Sep;72(3):377-80. Thromb Haemost. 1994. PMID: 7855787
-
[Low molecular weight heparins].Pathol Biol (Paris). 1986 Jan;34(1):61-9. Pathol Biol (Paris). 1986. PMID: 3517772 Review. French.
-
Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments.Semin Thromb Hemost. 1985 Jan;11(1):56-74. doi: 10.1055/s-2007-1004360. Semin Thromb Hemost. 1985. PMID: 3883500 Review.
Cited by
-
Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.J Thromb Thrombolysis. 2016 Apr;41(3):475-81. doi: 10.1007/s11239-015-1231-5. J Thromb Thrombolysis. 2016. PMID: 25982217 Review.
-
[Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].Klin Wochenschr. 1986 Nov 17;64(22):1171-5. doi: 10.1007/BF01728455. Klin Wochenschr. 1986. PMID: 3807263 German.
-
Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.J Clin Invest. 1985 Apr;75(4):1169-73. doi: 10.1172/JCI111812. J Clin Invest. 1985. PMID: 3988937 Free PMC article.
-
A low molecular weight heparin in hemodialysis.Klin Wochenschr. 1988 Mar 15;66(6):246-9. doi: 10.1007/BF01748164. Klin Wochenschr. 1988. PMID: 2835544
-
Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.Drugs. 1990 Oct;40(4):498-530. doi: 10.2165/00003495-199040040-00003. Drugs. 1990. PMID: 1964634 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical